Assoc. Prof. Vilém Rohn CSc., MD
Future Forces Forum
World CBRN & MEDICAL Congress (CEBIRAM) 2018
Future Forces Exhibition 2018
Chief
Charles University Teaching Hospital, Department of Cardiovascular Surgery, Prague, Czech Republic
Presentation
POSTER PRESENTER
Extracorporeal membranous oxygenation therapy for chemical warfare agent and smoke intoxication
The risks and threats from biological and chemical weapon systems may be increasing with an evolution of hybrid and asymmetrical warfare. Treatment options at point of injury and ROLE I and Role II NATO oriented facilities focus on chemical warfare agent, thermal and smoke exposure. The core of therapy, however, remains symptomatic and supportive. The gap of conventional treatment that may be inadequate may be significant. One of the most aggressive a possibly promising modality for definitive treatment is prehospital extracorporeal membrane oxygenation (ECMO). ECMO can provide cardiac and respiratory support for patients whose heart and lungs cannot perform their functions adequately. This hi-tech yet accessible technology can be understood as being artificial heart and lungs, standing outside the patient, connected by tubing, supporting vital functions and increasing survivability from preventable traumatic and other illness from warfighting injuries. ECMO alone cannot remove or neutralize any toxic agents but can provide sufficient hemodynamic support and oxygenation until patients are transported to the hospital, and the elimination of the toxic agent the medical doctors or patients themselves provide in the hospital.
Curriculum Vitae
Date of birth January 22, 1960
Birthplace Kadaň (Czech Republic)
Nationality Czech
Present appointment Charles University Teaching Hospital
Department of Cardiovascular Surgery
Prague, Czech Republic
Education and training:
1986 Graduation M.D.
Faculty of Medicine, Charles University Prague,
Czech Republic
1990 board examination in general surgery
1993 PhD graduation, Thesis: Prevention of coronary artery bypass grafts occlusion and control of neointimal hyperplasia in autologous venous bypasses by indobufen.
1995 board examination in vascular surgery
1997 board examination in cardiac surgery
2011 appointed associate professor of surgery at the 1st Medical Faculty Charles University in Prague, Thesis: Current problems of surgical treatment of coronary artery disease - arterial myocardial revascularization and ischemic mitral insufficiency (Review and own results).
Profesional experience:
1986 - 1990 senior house officer in Dept. of Cardiovascular and Transplant Surgery IKEM
Prague
1990 - January - May - Surgical dept. Hospital Pelhřimov (Czech Rep.) -head Dr. Křikava
1990 - 1995 registrar in vascular surgery - Dept. of Cardiovascular and Transplant
Surgery Institute of Clinical and Experimental Medicine (IKEM), Prague
1995 - 1997 registrar in cardiac surgery - Dept. of Cardiovascular and Transplant
Surgery IKEM, Prague
1996 - January - July - Dept. of Cardiac Surgery (center E. Malan), Milano University Hospital - head surgeon Dr. Menicanti
1997 - 2002 – Consultant cardiac surgeon - Dept. of Cardiovascular and Transplant Surgery IKEM, Prague
2002 – Feb 2005 - deputy head cardiac surgeon - Dept. of Cardiovascular and Transplant Surgery IKEM, Prague
Feb 2005 – 2014, deputy head cardiac surgeon Department of Cardiovascular Surgery, Charles University Teaching Hospital, Prague
Feb 2006 – Aug 2006 – Cardiac Surgery Consultant, Soliman Fakeeh Hospital, Jeddah, Saudi Arabia
July 2008 - Cardiac Surgery Consultant, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
July 2009 - Cardiac Surgery Consultant, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia
February 2014- now – Head of Department of Cardiovascular Surgery, University Hospital Motol and 2-nd Faculty of Medicine Charles University Prague
Membership:
Česká společnost kardiovaskulární chirurgie (Czech Society of Cardiovascular Surgery)
European Association for Cardio-thoracic Surgery
Society of Thoracic Surgeons, USA
